AI is quietly becoming a major trade story. Recent China export data shows strong shipments of AI related products, even as wider U.S. China tech tensions continue. That underlines how real demand for chips, software and cloud capacity is already flowing through global supply chains. This article looks at 3 stocks from our AI Stocks screener that sit in the slipstream of that trend.
The 3 AI stocks covered below are only a sample, since the full screen surfaced 14 more companies with equally compelling narratives across chips, software and cloud that are not covered here. To identify and analyze the highest conviction opportunities in this theme, head straight into the Artificial Intelligence/ AI Stocks screener.
Aura Consolidated Group (ASX:AXQ) runs a broad digital safety platform that covers credit monitoring, identity theft protection, VPN and privacy tools, antivirus, password management, spam call blocking and child online safety features for consumers, families and employees. All of its reported US$192.52 million in revenue comes from Security Software & Services, with operations currently reported out of Australia. The stock carries a market cap of about A$756.1 million.
Investors watching AI in cybersecurity may wish to keep Aura Consolidated Group on their radar. The company has reported revenue growth of 31.3% a year and focuses squarely on subscription-style digital safety services. It is still loss making with a reported net loss of US$140.78 million and a very short cash runway. The July IPO and fresh capital raise introduce both funding relief and execution risk, particularly given an inexperienced board and management team and highly illiquid shares. Aura’s upcoming Q2 2026 results on 6 August will be an early indication of how this new listing is balancing growth, cash burn and product investment that uses AI.
Revenue growth at Aura Consolidated Group is racing ahead, while losses and a short cash runway keep questions alive. Get the full story in the 1 key reward and 3 important warning signs (2 are major!)
Aura Consolidated Group and the two other stocks in this article all came from a single screener, but the real edge comes when you set the rules yourself. Use our flexible Screener to mix metrics like valuation, growth, balance sheet strength and risks, or start with any of our curated Investing Ideas.
Xero provides cloud based accounting, payroll, payments and workflow tools for small businesses and their advisors, all delivered through its Xero platform and connected products like Planday, Hubdoc, Syft and Melio. The company generates all of its NZ$2.75b in revenue from providing online solutions for these customers, and serves markets across Australia, New Zealand, the UK, the US and the rest of the world. Xero has a market cap of about A$13.1b.
Xero sits in the path of AI reshaping back office work, with 20% revenue growth, high gross margins near 88% and a growing set of AI powered features such as JAX, Industry Benchmarks and tight integrations with Microsoft 365 and Anthropic’s Claude. Forecast earnings growth of around 30% a year and revenue guidance of NZ$3.62b to NZ$3.73b for FY2027 reflect the level of investor expectations for the business model to scale, even after a year where net margins slipped to 6.1% and earnings declined. The stock trades on a rich P/E multiple and has underperformed the Australian software sector, while leverage is fully from external funding and return on equity is only 3.1%. For investors who are prepared to pay a premium for established software businesses with a significant AI component, the combination of strong product adoption and a relatively new management team makes Xero an investment story that warrants closer consideration, while still involving meaningful risks.
Xero’s accelerating AI tools, rich P/E and modest 3.1% return on equity leave a big question: Is the market paying up for the right reasons or missing something in the analyst forecasts for Xero?
Echo IQ uses AI diagnostics to help cardiologists spot structural heart disease such as aortic stenosis, diastolic dysfunction and heart failure earlier and more consistently. The company currently reports about A$0.09 million in revenue from developing its artificial intelligence software and has a market cap of roughly A$1.1b, which shows how much the market is focusing on its potential rather than its current scale.
Echo IQ is attracting attention because it sits at the intersection of AI and healthcare, with its EchoSolv platform and a research collaboration with Mayo Clinic to test cardiac risk scores in oncology patients. Analysts expect rapid revenue growth and see more than 20% upside from current prices. However, the stock is still very early stage, loss making and funded through higher risk borrowing. The recent A$110 million equity raise and new CFO with deep medical technology experience give the company more firepower and credibility. For investors who can tolerate volatility and execution risk, Echo IQ offers a focused way to get exposure to AI driven medical diagnostics while the full story is still developing.
Echo IQ’s tiny A$0.09 million revenue, sitting against a roughly A$1.1b market cap, suggests investors see something big forming. Get the deeper context in the analyst forecasts for Echo IQ
Fresh ideas often move first. By the time every investor sees a breakout, early momentum is already in motion. Scan these under the radar for now opportunities before the crowd and consider your options.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com